Literature DB >> 13194851

A five-year assessment of patients in a controlled trial of streptomycin in pulmonary tuberculosis; report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council.

W FOX, I SUTHERLAND, M DANIELS.   

Abstract

Entities:  

Keywords:  STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy

Mesh:

Substances:

Year:  1954        PMID: 13194851

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


× No keyword cloud information.
  10 in total

1.  The role of the host in the chemotherapy of tuberculosis.

Authors:  P D HART
Journal:  Br Med J       Date:  1954-10-02

2.  [The significance of tubercle bacillis resistance against lowered ethionamide concentrations for successful treatment].

Authors:  D Vána; M Slosárek
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1967

Review 3.  The chemotherapy of tuberculosis: past, present and future.

Authors:  D Mitchison; G Davies
Journal:  Int J Tuberc Lung Dis       Date:  2012-06       Impact factor: 2.373

4.  A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India.

Authors: 
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

Review 5.  Tuberculosis treatment and drug regimens.

Authors:  Giovanni Sotgiu; Rosella Centis; Lia D'ambrosio; Giovanni Battista Migliori
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-08       Impact factor: 6.915

6.  Assessment of the Efficacy of New Anti-Tuberculosis Drugs.

Authors:  Denis A Mitchison; Geraint R Davies
Journal:  Open Infect Dis J       Date:  2008-12

7.  Progress in the second and third years of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.

Authors:  S DEVADATTA; R H ANDREWS; J H ANGEL; A L BHATIA; W FOX; B JANARDHANAM; S RADHAKRISHNA; C V RAMAKRISHNAN; T V SUBBAIAH; S VELU
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

Review 8.  Can we prevent antimicrobial resistance by using antimicrobials better?

Authors:  Germander Soothill; Yanmin Hu; Anthony Coates
Journal:  Pathogens       Date:  2013-06-10

Review 9.  Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.

Authors:  Patrick P J Phillips; Carole D Mitnick; James D Neaton; Payam Nahid; Christian Lienhardt; Andrew J Nunn
Journal:  PLoS Med       Date:  2019-03-22       Impact factor: 11.069

Review 10.  Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine.

Authors:  Sydney Stanley; Qingyun Liu; Sarah M Fortune
Journal:  Front Cell Infect Microbiol       Date:  2022-10-03       Impact factor: 6.073

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.